ADRCs

DEVICE2 trials

Sponsors

Paracrine, INC.

Conditions

Diabetic Foot UlcerScleroderma, Diffuse

Phase 3

Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers

Paracrine, INC.Diabetic Foot Ulcer

Start: 2023-02-28End: 2025-07-31Target: 290Updated: 2022-09-28

ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma

Paracrine, INC.Scleroderma, Diffuse

Start: 2023-02-28End: 2025-12-30Target: 174Updated: 2022-09-28

Related Papers

RJX Improves Wound Healing in Diabetic Rats

Frontiers in Endocrinology2022-06-0213 citations